Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 32.96 | N/A |
| PEG Ratio (TTM) | -0.49 | N/A |
| P/S Ratio (TTM) | 0.24 | N/A |
| P/B Ratio (TTM) | 0.73 | N/A |
| P/FCF Ratio (TTM) | 9.11 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.50 | N/A |
| Price to 5YR AVG FCF Ratio | 5.86 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.60% | N/A |
| ROE (TTM) | 2.21% | N/A |
| Net Profit Margin (TTM) | 0.74% | N/A |
| ROIC 5YR AVG | 8.31% | N/A |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -44.99% | 475.95% | 365.18% |
| Revenue | 16.47% | 1.04% | 4.12% |
| Net Income | -45.43% | 478.86% | 367.00% |
| Cash Flow | -31.03% | 72.06% | 59.79% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.78 | N/A |
| Quick Ratio (TTM) | 1.13 | N/A |
| D/E Ratio (TTM) | 1.73 | N/A |
| Interest Coverage (TTM) | 1.50 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | 1.58 | N/A |
| LTL to 5YR AVG FCF | 6.16 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.46% | N/A |